Intractable & Rare Diseases Research
Scope & Guideline
Illuminating Paths in Rare Disease Research.
Introduction
Aims and Scopes
- Epidemiology of Rare Diseases:
The journal emphasizes the importance of understanding the prevalence and distribution of rare diseases, including comprehensive epidemiological studies that highlight the burden these conditions place on healthcare systems. - Genetic and Molecular Research:
Research on the genetic underpinnings of rare diseases is a core focus, including studies on genetic mutations, biomarkers, and the development of genetic diagnostics that facilitate better patient management. - Clinical Management and Treatment Approaches:
Papers often explore novel treatment strategies and management protocols for rare diseases, including case studies, clinical trials, and reviews that contribute to improved patient outcomes. - Patient-Centered Research:
The journal prioritizes research that includes patient perspectives, quality of life assessments, and psychosocial impacts of living with rare diseases, fostering a holistic understanding of these conditions. - Innovative Technologies in Rare Disease Research:
There is a consistent interest in the application of advanced technologies, such as artificial intelligence and metabolomics, to improve diagnostics, treatment efficacy, and understanding of disease mechanisms.
Trending and Emerging
- Integration of Artificial Intelligence in Rare Disease Research:
A significant trend is the increasing incorporation of artificial intelligence technologies in diagnosing and managing rare diseases, showcasing innovative methodologies that enhance precision medicine. - Focus on Quality of Life and Patient Experiences:
There is a growing emphasis on understanding the quality of life and psychological impacts of rare diseases, indicating a shift towards more holistic patient-centered research. - Innovations in Genetic Diagnostics:
Emerging themes include advances in genetic diagnostics, such as whole-exome sequencing and next-generation sequencing technologies, which are revolutionizing the understanding and management of genetic disorders. - Interdisciplinary Collaborations:
Research that involves interdisciplinary approaches, combining insights from genetics, epidemiology, and clinical practice, is increasingly prominent, reflecting the complex nature of rare diseases. - Emerging Treatments and Therapeutics:
There is a rising interest in novel therapeutic approaches, including gene therapies and personalized medicine strategies, that promise to address unmet needs in rare disease treatment.
Declining or Waning
- General Reviews of Rare Diseases:
There has been a noticeable decrease in broader reviews of rare diseases as more targeted, specific studies emerge. The focus is shifting towards in-depth analyses rather than general overviews. - Historical Perspectives:
Papers that provide historical context or retrospective analyses of rare diseases are appearing less frequently, suggesting a trend towards more forward-looking research that emphasizes current issues and future directions. - Basic Science without Clinical Relevance:
Research that delves into basic science aspects of rare diseases without a clear clinical application or relevance is becoming less common, as the journal increasingly favors studies that bridge the gap between laboratory findings and clinical practice. - Epidemiological Studies in Developed Regions:
There appears to be a waning interest in epidemiological studies focused solely on developed countries, likely as the journal aims to highlight the global burden of rare diseases, particularly in under-researched regions.
Similar Journals
Annals of Medicine and Surgery
Innovative Insights for Healthcare ProfessionalsAnnals of Medicine and Surgery is a reputable multidisciplinary journal published by Lippincott Williams & Wilkins, focusing on a broad range of topics pertinent to both medicine and surgery. With an ISSN of 2049-0801, this journal aims to disseminate innovative research findings and clinical studies that contribute to the advancement of medical and surgical practices. Since its inception in 2012, it has established itself within the academic community, achieving a Q3 ranking in both the Medicine (miscellaneous) and Surgery categories for 2022. Despite its coverage being discontinued in Scopus, the journal continues to receive attention, ranked in the 45th percentile for its fields, illustrating its growing influence. Researchers, healthcare professionals, and students will find in this journal an invaluable resource for enhancing their understanding and staying updated with evolving medical and surgical landscapes. Access options are currently managed through institutional subscriptions, ensuring the dissemination of high-quality research to a diverse audience.
Expert Opinion on Orphan Drugs
Illuminating the path from research to real-world impact.Expert Opinion on Orphan Drugs is a pivotal academic journal published by Taylor & Francis Ltd, focusing on the burgeoning field of orphan drugs, which are often essential for treating rare diseases. As an integral source of insights and advancements from 2013 to 2024, this journal aims to bridge the gap between emerging scientific research and clinical application, providing a platform for authors to discuss pharmacological innovations and policy implications. With its ISSN 2167-8707, the journal has established a reputably rigorous editorial process and is indexed in Scopus, showcasing its relevance with ranks in various pharmacology and health policy disciplines. Though currently not an open-access journal, it endeavors to deliver high-quality articles that are vital for researchers, healthcare professionals, and policy makers aiming to navigate the complexities and challenges in the orphan drug landscape. It is categorized in Q4 for Health Policy and Q3 for Pharmacology in recent evaluations, reflecting its accessible yet scholarly contributions to this niche area of medical research.
SAGE Open Medical Case Reports
Empowering Healthcare Through Open InsightsSAGE Open Medical Case Reports, published by SAGE Publications Inc, is a pioneering open-access journal dedicated to the rapid dissemination of medical case reports that significantly contribute to clinical knowledge and practice. Since its launch in 2013, this journal has become a valuable resource for healthcare professionals, researchers, and students in the field of medicine, facilitating the exchange of unique clinical experiences from around the globe. While the journal is categorized as Q4 in the Medicine (miscellaneous) quartile and holds a Scopus rank of 423 out of 636 in the General Medicine category, the accessibility of its content underscores its commitment to enhancing medical education and informing practice. With no subscription barriers, it supports the sharing of critical insights appropriate to a diverse audience, thereby fostering a culture of innovation and collaboration in healthcare.
International Journal of Clinical and Experimental Pathology
Fostering Collaboration in the World of PathologyInternational Journal of Clinical and Experimental Pathology, published by E-CENTURY PUBLISHING CORP, serves as a vital resource for professionals in the field of pathology. With its ISSN 1936-2625, the journal has positioned itself within the competitive landscape of medical journals, achieving commendable rankings in Scopus, particularly in the categories of Pathology and Forensic Medicine (Rank #98/185) and Histology (Rank #38/58). Although its coverage in Scopus has been discontinued, the journal’s past contributions from 2009 to 2017 continue to be a touchstone for researchers interested in advancing their understanding of clinical and experimental pathology. The open-access format ensures accessibility to a wide audience, fostering collaboration and education in this essential medical discipline. By bridging clinical research and experimental findings, this journal plays a crucial role in disseminating knowledge and enhancing practices within pathology, making it an indispensable tool for researchers, professionals, and students alike.
ORVOSI HETILAP
Fostering Interdisciplinary Insights in HealthcareORVOSI HETILAP is a pivotal journal in the field of general medicine, published by AKADEMIAI KIADO ZRT in Hungary. With its rich history dating back to 1949, this journal has been a platform for disseminating significant research findings and clinical advancements that impact healthcare practices. Although it currently falls within the Q4 category in the 2023 ranking of Medicine (miscellaneous), it holds a Scopus rank of #320 among 636 journals in its category, indicating its growing recognition among peers and scholars. The journal does not offer open access options, which may limit broader dissemination, but it nonetheless remains an important resource for medical professionals, researchers, and students engaging with contemporary medical issues. Located in the vibrant academic landscape of Budapest, ORVOSI HETILAP continues to contribute to the evolving dialogue in the medical community, showcasing diverse topics and fostering interdisciplinary collaboration.
KLINISCHE PADIATRIE
Bridging Research and Practice for Healthier FuturesKLINISCHE PADIATRIE is a prominent academic journal published by GEORG THIEME VERLAG KG since its inception in 1972. Based in Germany, this journal serves as a valuable resource for professionals and researchers in the fields of Pediatrics, Perinatology, and Child Health. With an ISSN of 0300-8630 and E-ISSN 1439-3824, it features a rich array of peer-reviewed articles that focus on child health and development, encompassing clinical practices, therapeutic advances, and interdisciplinary approaches to pediatric care. While the journal operates on a subscription basis, its impact within the academic community is evidenced by its ranking of Q3 in Pediatrics, Perinatology, and Child Health as of 2023, and it maintains a solid standing within Q4 in Medicine (miscellaneous). The journal aims to bridge the gap between emerging research and clinical practice, providing a platform for innovative ideas that enhance pediatric care. Researchers, medical professionals, and students alike will find KLINISCHE PADIATRIE an essential addition to their academic repertoire, fostering advancements in pediatric healthcare and enriching knowledge in this vital field.
Clinical Medicine & Research
Transforming healthcare delivery with groundbreaking insights.Clinical Medicine & Research is a premier peer-reviewed journal published by Marshfield Clinic, dedicated to advancing the field of medical science with a focus on clinical and community-based care. Established in 2003, the journal showcases groundbreaking research and innovative practices aimed at improving patient outcomes and optimizing healthcare delivery. With an ISSN of 1539-4182 and an E-ISSN of 1554-6179, it has garnered recognition in the academic community, achieving a Q2 ranking in Community and Home Care and a Q3 ranking in Miscellaneous Medicine categories as of 2023. The journal’s Scopus rankings further emphasize its relevance, placing it at #263 in General Medicine and #20 in Community and Home Care. Although it operates under a subscription model, Clinical Medicine & Research remains pivotal for researchers, professionals, and students seeking to stay informed about the latest advancements in clinical practice and healthcare methodologies, with an eye toward its impact on the broader medical landscape through 2024 and beyond.
AME Case Reports
Fostering Scholarly Exchange for Better Patient OutcomesAME Case Reports, published by AME PUBLISHING COMPANY, is a peer-reviewed open-access journal dedicated to the dissemination of high-quality clinical case reports across various medical disciplines. With an expanding focus on innovative medical practices and clinical experiences, this journal serves as an essential platform for healthcare professionals, researchers, and medical students to share significant findings and insights that contribute to evidence-based practices. Although specific metrics such as impact factors and H-index are not currently available, the journal's commitment to academic rigor and accessibility fosters an environment for scholarly exchange and professional development. The publication facilitates immediate access to important case studies that may inform clinical decisions and improve patient care. In an era where sharing specialized knowledge is paramount, AME Case Reports stands as a vital resource for those involved in the medical community worldwide.
Case Reports in Medicine
Exploring the nuances of medicine through compelling case reports.Case Reports in Medicine is a distinguished journal published by HINDAWI LTD, focusing on the vital field of medical case studies and reports. Since its inception in 2009, this Open Access journal has offered a platform for sharing novel insights, challenges, and outcomes encountered in clinical practice. Located in the United States, it serves a global audience of researchers and healthcare professionals, emphasizing the importance of case reports in advancing medical knowledge and promoting evidence-based practice. With an impressive ranking of Q3 in Medicine (miscellaneous) and a solid performance at #265/636 in General Medicine (58th percentile) as per Scopus, the journal is recognized for its impactful contributions to the medical community. Through its commitment to disseminating quality research, Case Reports in Medicine plays a crucial role in fostering collaboration and enhancing patient care worldwide, making it an essential resource for students, researchers, and practitioners alike.
Clinical Pathology
Unlocking Insights for Enhanced Diagnostic PracticesClinical Pathology, an esteemed journal published by SAGE Publications Ltd, stands at the forefront of advancing knowledge in the intersection of histology, microbiology, and pathology. As an Open Access journal since 2019, it provides researchers and healthcare professionals seamless access to high-quality, peer-reviewed articles that contribute to the field's growing body of knowledge. With a focus on enhancing diagnostic methodologies and advancing clinical applications, Clinical Pathology serves a diverse audience eager to explore innovative research and practical insights. The journal currently holds Q3 status in Histology and Pathology and Forensic Medicine, and Q4 in Medical Microbiology, reflecting its commitment to rigorous scholarship within a competitive landscape. Its ranking in Scopus further positions it as a vital resource for professionals striving for excellence in clinical and experimental pathology. We invite researchers, students, and professionals to engage with the latest findings and share their valuable contributions to help propel the field forward.